Time-sensitive and reliable cancer news, research and analysis
covering clinical trials, drugs, treatments and cures worldwide
|For 24/7 unlimited access...|
or call us on: +43 (0)1 71 72 8 900 (Vienna)
or on: +44 (0)20 7769 6707 (London)
Cancer Stat is the global benchmark for reliable and time-sensitive cancer news, research and analysis.
Its user-friendly online platform and its extensive email services cover everything from upcoming clinical trials, to the real-time approval of new cancer drugs and treatments worldwide.
Our service provides corporates, healthcare and pharmaceutical professionals, consultants, and cancer patients with personalised and indepth 24/7 treatment news, and extensive updates on all types of cancer.
Corporates are able to follow news and analysis on the daily activities of 6,368 pharmaceutical and healthcare companies worldwide. Patients are able to follow news and research on the treatments that they are receiving, and on the alternatives, from reliable and reputable sources.
Whether you are a professional or a patient, you have your own login account enabling you to access the whole service, and to view and to receive exactly what you want when you need it.
Cancer Stat is designed to provide invaluable information and research results to professionals and patients worldwide.
Our aim is to provide professionals and patients with the highest corporate level of cancer news and intelligence - the type of service that until now has only been dreamt of by those in need of such a service.
Our goal is to ensure that professionals and patients are alerted to new clinical trials, drugs, treatment options and medical breakthroughs that have been made worldwide - as they happen.
Our pricing options are simple. There is one structure for corporates/professionals, and another special discounted structure for patients and their family.
1. Corporates/Professionals (Healthcare & Pharmaceutical)
For corporates/professionals the service costs €720/£720 a year per user. This works out at €60/£60 a month per user.
Corporates/professionals can subscribe to Cancer Stat by contacting us directly:
- by email: firstname.lastname@example.org
- by phone:
Vienna office, Austria, European Union: +43 (0)1 71 71 8 900
London office, United Kingdom: +44 (0)20 7769 6707
You have the option of taking a 3 week free trial to Cancer Stat before subscribing.
Patients/family can subscribe to Cancer Stat at a special discounted rate by either of the following methods:
a. Making a single payment of £240 for a year's subscription via PayPal.
b. Paying £30 a month for an ongoing monthly subscription via PayPal.
Both options provide you with your own personal Cancer Stat account and can be found at: www.cancerstat.com/accounts/subscribe
You will have full access to all platform features and to the extensive email services. You can also request that drugs or treatments that are of special interest to you are added and tracked.
The technology that we have developed behind our service ensures that Cancer Stat is quick and user-friendly. Whether you are a professional or a patient, Cancer Stat provides you with the exact customised information that you require on a minute by minute basis.
Our service provides detailed statistical analysis enabling you to discover which drugs and treatments are being developed and provided to combat specific types of cancer.
Detailed news, information and intelligence are provided on the activities of the pharmaceutical companies developing and producing cancer drugs.
Cancer Stat tracks cancer news and research worldwide. It is not limited to one continent or to one language.
You are able to request that drugs and treatments of specific interest to you personally are added and tracked by our service.
Cancer Stat also provides indepth and reliable information on more than 100 other illnesses, conditions and health concerns. These include Covid-19, Alzheimer's, Diabetes, IVF, Parkinson's, Obesity and Heart Disease.
Until now, there had not been a service in existence that provided on demand, reliable, comprehensive and cutting-edge global cancer news and research.
Neither had there been a global service that provided automated and interactive updates on the newest clinical trials, treatments and cures that were of specific and personal interest to healthcare professionals and cancer patients.
Our team decided to rectify this situation. We adapted the sophisticated research technology and the investigative know-how that we have developed over the past decade within other sectors to create Cancer Stat.
Cancer Stat has been created to empower corporates, healthcare professionals and cancer patients worldwide so that they become supremely informed.
To do our best to help save lives worldwide.